• Aucun résultat trouvé

PAFs ARGENTINA

N/A
N/A
Protected

Academic year: 2022

Partager "PAFs ARGENTINA"

Copied!
2
0
0

Texte intégral

(1)

ARGENTINA

Total # cancer cases (2018)

Total # cancer deaths (2018)

129,047 68,778

25.1%

aPAF, cancer deaths bPAF, cancer cases cPAF, melanoma cases

TRENDS

Estimated past and future trends in total cases per year (breast and lung) Probability of premature death from cancer per year

INVESTMENT CASE (2019)

*Upper middle income

At this income level, investing in a package of essential services and scaling-up coverage will:

Costs per year Projected lives saved per year

BURDEN OF CANCER

37.3%

Total population (2019)

Tobacco (2017)a Alcohol (2016)a Infections (2012)b Obesity (2012)b

9.6% 6.8%

44,780,675

Premature deaths from NCDs (2016)

Cancer as % of NCD premature deaths (2016)

6.5%

PAFs

(population attributable fractions)

80,994

Cancer Country Profile 2020

UV (2012)c Occupational risk (2017)a

52.8% 3.2%

16.7%

2.8%

3.5%

12.2%

3.8%

9.0%

3.8%

9.0%

3.1%

2.7%

9.3%

2.3%

3.2%

12.7%

3.4%

15.5%

6.8%

5.8%

4.7%

0.4%

Breast Bladder Cervix uteri Colorectum Kidney Lung Pancreas Prostate Stomach Thyroid

Most common cancer cases (2018)

Incidence Mortality

0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000

2020 2022 2024 2026 2028 2030

9.07%

8.87%8.83%8.84%8.74%8.72%8.61%8.62%8.47%8.33%8.21%8.07%8.09%8.04%

7.74%

7.54%7.45%7.37%7.28%7.20%7.12%7.03%6.95%6.86%6.78%6.70%6.61%

6.53%

7.22%7.05%6.87%6.70%6.52%6.35%6.18%6.00%5.83%5.66%5.48%5.31%

5.14%

2.00%

7.00%

12.00%

17.00%

2000 2005 2010 2015 2020 2025 2030

Past trends Projected linear trend SDG target 19,386

11,244 21,558

11,595 30,124

17,855

- 5,000 10,000 15,000 20,000 25,000 30,000 35,000

Breast cancer Lung cancer

2012 2018 2040

- 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00 9.00

2020 2022 2024 2026 2028 2030

US$ (per capita)

(2)

ARGENTINA

HEALTH SYSTEM CAPACITY

aper 10,000 cancer patients

WORKFORCE

aper 10,000 cancer patients

Quality of mortality registration*** 2007-2016 Medium 2019 no

# of radiation oncologista 2019 n/a

2019 12.9

# of mammographsa 2020 46.5 # of surgeonsa n/a n/a

# of CT scannersa 2020 147.2 # of radiologista 2019 310.0

# of MRI scannersa 2020 50.4 # of nuclear medicine physiciana 2019 31.4

# of PET or PET/CT scannersa 2020 3.0 # of medical & pathology lab scientistsa 2004 1521.1

Integrated NCD plan 2019 operational 2019 n/a

NCCP (including cancer types) 2019 operational 2019 4 cancer(s)

MPOWER measures fully implemented and

achieved 2018

3

Pathology services 2019 generally available

Cancer management guidelines 2019 yes 2019 don't know

Palliative care included in their operational,

integrated NCD plan 2019 no

2015-2017 721

Breast cancer screening program 2019 yes

*Defined daily doses for statistical purposes (S-DDD) per miliion inhabitants per day Breast cancer screening program: Starting

age, target population 2019

50

GLOBAL INITIATIVES

Elimination of Cervical Cancer Global Initiative for Childhood Cancer

HPV vaccination programme coverage 2018 57.1 2020 1490

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 yes

Screening programme type 2019 organised Defined referral system 2019 yes

Screening programme method 2019 HPV test

Screening participation rates 2019

Early detection programme/guidelines 2019 yes

Defined referral system 2019 yes

don't know

Annual cancer cases (0-14 years old) Bone marrow transplantation capacity

# Public cancer centres per 10,000 cancer patients

# of treatment services (surgery,

radiotherapy, chemotherapy) 2019 3 Availability of opioids* for pain

management Availability of population-based cancer

registry (PBCR)** 2019

# of external beam radiotherapy (photon,electron)a

Cancer Country Profile 2020

High quality PBCR

2019 9.3

FORMULATING RESPONSE

Annual cancer cases (0-14 years old) Palliative care availability:

community/home-based care 2019 don't know

Available staff in Ministry of Health who dedicates significant proportion of their time to cancer

# of medical physicista

Early detection programme/ guidelines for 4 cancers (breast, cervix, colon, childhood)

392

52 103 25

60 58 800

Acute lymphoid leukaemia Hodgkin lymphoma Burkitt lymphoma CNS, low grade tumours Retinoblastoma Wilms tumour Other childhood cancer

Références

Documents relatifs

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no. Screening programme type 2019 organised Defined referral system

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no. Screening programme type 2019 organised Defined referral system

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 yes. Screening programme type 2019 opportunistic Defined referral system

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no. Screening programme type 2019 organised Defined referral

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no. Screening programme type 2019 organised Defined referral system

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no. Screening programme type 2019 organised Defined referral system

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 yes. Screening programme type 2019 organised Defined referral system

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 yes. Screening programme type 2019 organised Defined referral system